Clinical Trial

CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma

Name: CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma — clinical trial record (NCT07659678)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a prospective study to evaluate the sensitivity and specificity of Cu-64 DOTA-ECL1i PET/CT imaging to serve as a novel precision imaging tool for patients with head and neck squamous cell carcinoma (HNSCC).

Trial Details

NCT Number	NCT07659678
Lead Sponsor	Washington University School of Medicine Collaborators: National Cancer Institute (NCI)
Conditions	Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Head and Neck Squamous Cell Carcinoma HNSCC
Enrollment	90 participants
Start Date	2026-08-31
Primary Completion	2032-03-31 (estimated)
Study Completion	2032-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-22